Stock NAMS FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Frazier Lifesciences Acquisition Corporation

Equities

NAMS

NL00150012L7

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-06-04 pm EDT 		5-day change 1st Jan Change
19.22 EUR +1.91% Intraday chart for Frazier Lifesciences Acquisition Corporation +2.51% +72.07%
May. 21 NewAmsterdam Pharma Company N.V. to Present New Clinical and Preclinical Data Highlighting Obicetrapib's Impact on Key RiskFactors for Cardiovascular Disease at Upcoming Medical Meetings CI
May. 16 Transcript : NewAmsterdam Pharma Company N.V. - Special Call

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Bio Therapeutic Drugs
+1.91%+2.51%+72.07%+64.84% - 1.74B - - -
  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. Charts Frazier Lifesciences Acquisition Corporation
  5. Relative Strength Chart